vs
AGIOS PHARMACEUTICALS, INC.（AGIO）与ASP Isotopes Inc.（ASPI）财务数据对比。点击上方公司名可切换其他公司
AGIOS PHARMACEUTICALS, INC.的季度营收约是ASP Isotopes Inc.的1.2倍（$20.0M vs $16.7M），ASP Isotopes Inc.同比增速更快（1295.7% vs 86.1%），ASP Isotopes Inc.自由现金流更多（$-47.4M vs $-97.3M）
Agios Pharmaceuticals是一家美国上市制药企业，创立于2008年，专注于开发针对基因定义疾病的创新疗法，近期核心方向为溶血性贫血治疗药物，总部位于马萨诸塞州剑桥市，2013年7月完成首次公开募股。
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
AGIO vs ASPI — 直观对比
营收规模更大
AGIO
是对方的1.2倍
$16.7M
营收增速更快
ASPI
高出1209.6%
86.1%
自由现金流更多
ASPI
多$49.9M
$-97.3M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.0M | $16.7M |
| 净利润 | $-108.0M | — |
| 毛利率 | 90.6% | 12.5% |
| 营业利润率 | -608.9% | — |
| 净利率 | -541.1% | — |
| 营收同比 | 86.1% | 1295.7% |
| 净利润同比 | -11.9% | -586.8% |
| 每股收益（稀释后） | $-1.86 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGIOASPI
| Q4 25 | $20.0M | $16.7M | ||
| Q3 25 | $12.9M | $4.9M | ||
| Q2 25 | $12.5M | — | ||
| Q1 25 | $8.7M | — | ||
| Q4 24 | $10.7M | — | ||
| Q3 24 | $9.0M | — | ||
| Q2 24 | $8.6M | — | ||
| Q1 24 | $8.2M | — |
净利润AGIOASPI
| Q4 25 | $-108.0M | — | ||
| Q3 25 | $-103.4M | $-12.9M | ||
| Q2 25 | $-112.0M | — | ||
| Q1 25 | $-89.3M | — | ||
| Q4 24 | $-96.5M | — | ||
| Q3 24 | $947.9M | — | ||
| Q2 24 | $-96.1M | — | ||
| Q1 24 | $-81.5M | — |
毛利率AGIOASPI
| Q4 25 | 90.6% | 12.5% | ||
| Q3 25 | 87.0% | 8.7% | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
营业利润率AGIOASPI
| Q4 25 | -608.9% | — | ||
| Q3 25 | -907.4% | -306.1% | ||
| Q2 25 | -1020.1% | — | ||
| Q1 25 | -1222.0% | — | ||
| Q4 24 | -1165.3% | — | ||
| Q3 24 | -1146.9% | — | ||
| Q2 24 | -1228.3% | — | ||
| Q1 24 | -1124.3% | — |
净利率AGIOASPI
| Q4 25 | -541.1% | — | ||
| Q3 25 | -803.1% | -263.7% | ||
| Q2 25 | -899.4% | — | ||
| Q1 25 | -1023.3% | — | ||
| Q4 24 | -899.6% | — | ||
| Q3 24 | 10574.7% | — | ||
| Q2 24 | -1115.7% | — | ||
| Q1 24 | -995.8% | — |
每股收益（稀释后）AGIOASPI
| Q4 25 | $-1.86 | — | ||
| Q3 25 | $-1.78 | $-0.15 | ||
| Q2 25 | $-1.93 | — | ||
| Q1 25 | $-1.55 | — | ||
| Q4 24 | $-1.44 | — | ||
| Q3 24 | $16.22 | — | ||
| Q2 24 | $-1.69 | — | ||
| Q1 24 | $-1.45 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.1M | $333.3M |
| 总债务越低越好 | — | $14.4M |
| 股东权益账面价值 | $1.2B | $204.2M |
| 总资产 | $1.3B | $498.0M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资AGIOASPI
| Q4 25 | $89.1M | $333.3M | ||
| Q3 25 | $92.7M | $113.9M | ||
| Q2 25 | $80.9M | — | ||
| Q1 25 | $79.0M | — | ||
| Q4 24 | $76.2M | — | ||
| Q3 24 | $253.7M | — | ||
| Q2 24 | $84.5M | — | ||
| Q1 24 | $118.8M | — |
总债务AGIOASPI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $13.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AGIOASPI
| Q4 25 | $1.2B | $204.2M | ||
| Q3 25 | $1.3B | $74.1M | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $660.5M | — | ||
| Q1 24 | $743.9M | — |
总资产AGIOASPI
| Q4 25 | $1.3B | $498.0M | ||
| Q3 25 | $1.4B | $225.9M | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $773.1M | — | ||
| Q1 24 | $849.7M | — |
负债/权益比AGIOASPI
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-96.2M | $-37.8M |
| 自由现金流经营现金流 - 资本支出 | $-97.3M | $-47.4M |
| 自由现金流率自由现金流/营收 | -487.5% | -284.7% |
| 资本支出强度资本支出/营收 | 5.6% | 57.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-377.3M | — |
8季度趋势，按日历期对齐
经营现金流AGIOASPI
| Q4 25 | $-96.2M | $-37.8M | ||
| Q3 25 | $-88.2M | $-8.9M | ||
| Q2 25 | $-77.1M | — | ||
| Q1 25 | $-111.5M | — | ||
| Q4 24 | $-133.2M | — | ||
| Q3 24 | $-84.2M | — | ||
| Q2 24 | $-72.6M | — | ||
| Q1 24 | $-99.9M | — |
自由现金流AGIOASPI
| Q4 25 | $-97.3M | $-47.4M | ||
| Q3 25 | $-89.7M | $-12.0M | ||
| Q2 25 | $-78.0M | — | ||
| Q1 25 | $-112.3M | — | ||
| Q4 24 | $-134.1M | — | ||
| Q3 24 | $-84.6M | — | ||
| Q2 24 | $-72.7M | — | ||
| Q1 24 | $-100.0M | — |
自由现金流率AGIOASPI
| Q4 25 | -487.5% | -284.7% | ||
| Q3 25 | -696.5% | -245.5% | ||
| Q2 25 | -626.2% | — | ||
| Q1 25 | -1286.4% | — | ||
| Q4 24 | -1250.1% | — | ||
| Q3 24 | -944.2% | — | ||
| Q2 24 | -844.4% | — | ||
| Q1 24 | -1221.2% | — |
资本支出强度AGIOASPI
| Q4 25 | 5.6% | 57.9% | ||
| Q3 25 | 12.1% | 64.4% | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 8.8% | — | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 1.7% | — |
现金转化率AGIOASPI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
